ANALYST-UPGRADE

BIIB

BIOGEN INC.
BULLISH
Impact 4/10
Processed5mo ago SECanalyst-BIIB-wellsfar-20260420
Wells Fargo double upgrade: Equal-Weight → Overweight
Actionable Insight ▲ Bullish

A double upgrade from a mid-tier accuracy firm nine days before earnings, combined with aggressive institutional divergence and extreme short interest, sets up a high-conviction catalyst trade. Position for a short squeeze if results beat.

DirectionBullish
Final — all horizons settled through T+60d ⚠ clustered
BIIB ▲ +4.70% at T+60d
LONG call ✓ call won +4.70% · α vs SPY -1.38% · entry $183.33 → $191.95
Entry anchored
Apr 20, 12:16 PM ET
via exchange tick
T+1d
+1.01%
call +1.01% · α +1.66%
$185.18
settled 5mo ago
T+5d
-1.51%
call -1.51% · α -2.42%
$180.56
settled 5mo ago
T+20d
+4.31%
call +4.31% · α +0.11%
$191.23
settled 5mo ago
T+60d
+4.70%
call +4.70% · α -1.38%
$191.95
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Wells Fargo initiated a double upgrade from Equal-Weight to Overweight on the stock with a $250 price target, up from $200, citing improved fundamentals and valuation support. The move contrasts with a slightly bearish EPS revision trend, where 30-day estimates show more downgrades than upgrades across all periods. Consensus remains mixed: 40% Buy, 36.7% Hold, 3.3% Sell, with a mean target of $207.69 — Wells Fargo’s $250 PT is 20.4% above the mean. Institutional activity is split: FMR and Norges Bank made large new or expanded positions, while Renaissance and Wells Fargo Asset Management trimmed. Short interest is extremely elevated at 67.2% short ratio. With earnings due in nine days, this contrarian call from a firm with 55% accuracy (3.6% avg return) adds urgency. The rating change is a bullish outlier against a weakening analyst momentum backdrop.

Impact Score

Base Score
2/7
LLM Adjustment
+2
Final Score
4/10

Consensus & Targets

Buy / Strong Buy
20 (47%)
Hold
22
Sell / Strong Sell
1
Total Analysts
30
Mean PT
$207.69
Median PT
$203.50
High PT
$275.00
Low PT
$150.00
Current Price
$177.35
Implied Upside
+17.1%

Of 33 analysts, 40% rate Buy (13), 36.7% Hold (11), 3.3% Sell (1), and 0% Strong Sell. Consensus direction is neutral-to-slightly positive, though the high Hold count (22) reflects lingering caution. The upgrade from Wells Fargo moves it into the bullish minority.

The consensus mean price target is $207.69, median $203.50, range $150–$275. At a current price of $177.35, this implies 17.1% upside to the mean. Wells Fargo’s $250 target is 20.4% above the mean and 9.7% below the high target of $275, placing it in the top quartile of bullishness.

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-04-20Wells FargoupgradeOverweight$250.00
2026-04-14Piper SandlerupgradeOverweight$214.00
2026-04-13CitigroupmaintainNeutral$190.00
2026-04-13Truist SecuritiesmaintainHold$189.00
2026-04-10Morgan StanleymaintainEqual-Weight$200.00
2026-04-02HC Wainwright & Co.maintainBuy$237.00
2026-04-01Canaccord GenuitymaintainBuy$245.00
2026-04-01OppenheimermaintainOutperform$275.00
2026-03-17HSBCmaintainReduce$150.00
2026-02-23Freedom BrokermaintainHold$185.00

Over the past 30 days, there have been 2 upgrades (Wells Fargo, Piper Sandler) and 0 downgrades. EPS revisions are trending down: in the last 30 days, 4 downward revisions vs 0 upward for current year EPS; next year shows 1 up, 1 down. The 7-day revision trend shows minor stabilization with 2 upward revisions in the past week.

Firm Track Record — Wells Fargo

Wells Fargo accuracy: 55% on 6035 calls | avg return: 3.6%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
Jefferies100%2/213%top tier
Morgan Stanley83%5/65.5%top tier
Piper Sandler71%5/71.6%top tier
Wedbush67%4/62.1%top tier
JP Morgan67%2/32.5%top tier
HC Wainwright & Co.57%4/71.4%above average
UBS50%1/20.6%below average
Barclays50%2/4-2.8%below average
Canaccord Genuity50%1/2-2.1%below average
Goldman Sachs50%1/2-0.1%below average

Wells Fargo has a 55% accuracy rate (3,290 correct out of 6,035 rated calls) and an average return of 3.6% on rated stocks, placing it slightly above average. Among 15 firms covering the stock, it ranks 7th in accuracy — behind top-tier firms like Jefferies (100%), Morgan Stanley (83%), and Piper Sandler (71%), but ahead of UBS (50%) and RBC (47%).

Earnings Estimates

Next earnings: Apr 29, 2026

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
0q$3.01$1.66 — $4.68$2.3B↑1 ↓0
+1q$4.37$3.95 — $5.04$2.4B↑0 ↓0
0y$15.62$14.02 — $16.33$9.4B↑2 ↓0
+1y$15.88$14.34 — $17.60$9.4B↑2 ↓0

Cross-Platform Signals

Congressional
Gilbert Cisneros (democrat) — buy $1,001 - $15,000
Institutional
NORGES BANK — new
Institutional
FMR LLC — doubled (632%)
Institutional
WELLS FARGO & COMPANY/MN — trim (-32.3%)
Short Interest
Short: 408,399 | Exempt: 2 | TRF Vol: 607,748 | Short Ratio: 67.2% | Off-exchange volume (dark pool + OTC)

Institutional activity shows divergence: FMR LLC doubled down (+632%), and Norges Bank initiated a $464M position, signaling strong fundamental conviction. However, Renaissance Technologies slashed its stake by 58.6%, and Wells Fargo’s own asset arm trimmed by 32.3%. No insider trades reported. Congressional buys are minimal (1 small buy). Short interest is extreme at 67.2% short ratio, suggesting high bearish positioning ahead of earnings.

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

Report based on filing metadata.

25 reports for BIIB
Performance horizon
92% Hit rate 11 of 12 directional calls best @ T+60▲ +11.76%Jun 8, 2026
Filters
Rows
Reports for BIIB — sortable, filterable
TypeNow
Sep 3, 2026
28d ago
Press Release
NEUTRAL ★ 4/10
$220.83 $217.36▼ −1.57%▼ −0.36%$219.88 (−0.43%)
Sep 3, 2026
29d ago
Press Release
BULLISH ★ 7/10
$224.51 $217.15▼ −3.28%▼ −2.13%$219.88 (−2.06%)
Aug 6, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$207.94 $209.83▲ +0.91%▲ +0.51%$219.88 (+5.74%)
Jul 14, 2026
11w ago
Press Release
BULLISH ★ 7/10
$191.95 $199.95▲ +4.17%▲ +5.46%$219.88 (+14.55%)
Jul 13, 2026
11w ago
Press Release
BULLISH ★ 6/10
$191.95 $199.95▲ +4.17%▲ +5.46%$219.88 (+14.55%)
Jul 13, 2026
11w ago
ANALYST-UPGRADE
BULLISH ★ 3/10
—awaiting T+5——
Jun 17, 2026
15w ago
Press Release
NEUTRAL ★ 4/10
$196.58 $201.96▲ +2.74%▲ +4.40%$219.88 (+11.85%)
Jun 8, 2026
16w ago
ANALYST-UPGRADE
BULLISH ★ 2/10
$192.62 $198.64▲ +3.13%▲ +1.01%$219.88 (+14.15%)
Jun 4, 2026
17w ago
Press Release
NEUTRAL ★ 5/10
$195.82 $199.96▲ +2.12%▲ +4.67%$219.88 (+12.29%)
Jun 1, 2026
17w ago
Press Release
MIXED ★ 5/10
$192.22 $195.34▲ +1.63%▲ +4.38%$219.88 (+14.39%)
Showing 10 of 25

US Market Status

Market Closed — Opens Mon (65h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 20, 2026